In line with previous studies, this investigation suggests the associations among serum levels of IL-6, IL-1β, and IFN-γ and the lung cancer risk, underscoring the potential of these cytokines to act as risk biomarkers. This evidence concerns the gene IL6 and lung carcinoma.